Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
deals
dihydroergotamine
2
×
generic drugs
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
satsuma pharmaceuticals
startups
2
×
10x genomics
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
axial spondyloarthritis
bausch health
biogen
biotech ipos
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
cluster headache
crispr
desmoid tumors
detroit blog main
What
companies
approval
bio
biogen’s
biopharmaceutical
biotech
boost
convo
drug
earlier
failures
followed
genomics
haul
ipo
led
life
littered
markets
nash
new
news
price
public
remains
road
roundup
satsuma
science
springworks
strategy
street
talk
wall
way
wednesday
week
week’s
welcomed
Language
unset
Current search:
dihydroergotamine
×
startups
×
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
